The chairman of the Vaccine Strategy Orientation Council, Alain Fischer, said Thursday "rather to stay on the current recommendation" which reserves AstraZeneca's Covid-19 vaccine for over 55s.
"The risk analysis shows that the benefit of vaccination with the AstraZeneca vaccine for people under the age of 55 is not obvious, while it is massive beyond," he explained. during a press point organized by the ANRS health agency. Emerging infectious diseases.
Denmark dropped AstraZeneca from their list
This restriction was decided in mid-March by the High Authority for Health (HAS), because the rare cases of atypical thrombosis and coagulation disorders which had motivated his suspension for a few days were largely observed in children under 55 years.
Several other European countries have taken a similar step, while Denmark has ruled it out altogether.
The United Kingdom administers it to over 30s while some German regions offer it to everyone in exchange for a signed consent.
Expected data
The Minister of Health Olivier Véran announced last Friday that he had seized the HAS on the possibility of allowing all adults to receive this vaccine again, and under what conditions.
The HAS confirmed this referral to AFP on Wednesday and explained that it was waiting to rule on data from the expert committee convened by the Medicines Agency (ANSM) on this subject.
World
Coronavirus: The G7 commits to financially support the Covax vaccine sharing system
Health
Covid-19: What do we know about the contagiousness of vaccinated people?
Anti-covid vaccine
Coronavirus
Health
AstraZeneca